Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Paolo Lombardi
Paolo Lombardi
Naxospharma S.R.L

Graduated from Milan University (Italy), Ph.D. from Southampton University (UK), Paolo Lombardi has +35yr experience in the pharmaceutical industrial setting and backgrounds in organic synthetic chemistry, process research chemistry, and therapeutic chemistry. He held growing positions in Farmitalia Carlo Erba R&D where he achieved the goal of discovering Exemestane, launched in the global market under the name Aromasin™ for breast cancer therapy, and the clinical follow-on candidate Minamestane, as well as providing the relative manufacturing chemical technologies. As Vice-president for Chemistry in Menarini Ricerche, Paolo fostered the discovery of Sabarubicin, a 3rd generation antitumor anthracycline presently in advanced clinical studies. He acted as a consultant for the pharma company IBI G.Lorenzini and the French start-up biotech Chrysalon, before setting up his own science business. Inventor of +70 patents in Medicinal and Process Chemistry, author, and co-author of +150 research papers, reviews, abstracts, invited lectures, and seminars.

Research Interest

His research and innovation in the field of organic synthetic chemistry, process research chemistry, and therapeutic chemistry.

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
Sponsorship opportunity
General Enquiry
More details about

Authorization Policy

Copyright © 2019-2020 Allied Academies, All Rights Reserved.